The Movement Disorders Division within the Yale Department of Neurology comprises physicians and scientists dedicated to therecognition, evaluation, treatment, and understanding of the full range of movement disorders. The Yale Movement Disorders Clinic provides consultations and care for patients with Parkinson's disease and related illnesses, tremor disorders, Huntington's disease and other choreas, dystonias, tic disorders, myoclonus and other movement disorders either caused by primary nervous system dysfunction or secondary to medical illnesses and medications, including tardive dyskinesias. The group has a special interest in primary and secondary ataxias, gait disorders, restless legs syndrome and stiff-person syndrome. The treatment strategies include application of state-of-the-art medications for treatment of Parkinson's disease and other movement disorders as well as the use of botulinum toxins to treat a variety of movement disorders, spasticity (secondary to stroke, multiple sclerosis, cerebral palsy or trauma), and pain. The Yale Movement Disorders Clinic provides patient screening before deep brain stimulation (DBS) for refractory symptoms of Parkinson's disease, essential tremor and dystonias. The movement disorder specialists work closely with the stereotaxic neurosurgeons at Yale in preparation for DBS surgery and conduct DBS device programming and adjustment after surgery. The Movement Disorders Clinic is a multidisciplinary clinic and collaborates with clinicians and researchers associated with Yale Stereotactic and Functional Neurosurgery, Yale Neuropsychology, and Yale Neurogenetics.
|Jabbari, Bahman, MD||Professor of Neurology; Director, Division of Parkinson's disease and Movement Disorders; Director, Botulinum Toxin treatment program||(203) 785-4085 Appts
(203) 785-4937 Fax
|Machado, Duarte Goncalves, MD||Assistant Professor of Neurology; Lead Neurologist, Yale Health Center||(203) 785-4085 Appts
(203) 785-4937 Fax